<DOC>
	<DOCNO>NCT02402972</DOCNO>
	<brief_summary>To investigate whether intraoperative intraportal chemotherapy combine adjuvant chemotherapy treatment could improve disease-free survival ( DFS ) patient curative colorectal cancer resection compare adjuvant chemotherapy alone . This prospective , blind ( doctor do outcome measure mask ) , multi-center , 2-arm randomize controlled trial .</brief_summary>
	<brief_title>A Multi-center Randomized Controlled Trial Intraportal Chemotherapy Combined With Adjuvant Chemotherapy ( mFOLFOX6 ) Stage II III Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<criteria>1 . Age ≥ 18 ≤ 75 year ; 2 . Primary tumor undergone histologically confirm colon adenocarcinoma ; Colon cancer define presence inferior pole tumor peritoneal reflection ( least 15 cm anal margin ) . 3 . Together clinical radiological evidence Stage II ( T34 , N0 , M0 ) Stage III ( T14 , N12 , M0 ) disease ( accord 2007 revision International Union Against Cancer TNM stag system ) 4 . Performance status ( ECOG ) 0~1 5 . Adequate hematological function : Neutrophils≥1.5 x109/l platelet count≥100 x109/l ; Hb ≥9g/dl ( within 1 week prior randomization ) 6 . Adequate hepatic renal function : Serum bilirubin≤1.5 x upper limit normal ( ULN ) , alkaline phosphatase ≤5x ULN , serum transaminase ( either AST ALT ) ≤ 5 x ULN ( within 1 week prior randomization ) ; 7 . Written inform consent participation trial . 1 . Previous exposure prior cancer therapy ( chemotherapy , radiotherapy intervention therapy ) colon cancer . 2 . Patients know hypersensitivity reaction component study treatment . 3 . Other previous malignancy within 5 year , exception history previous basal cell carcinoma skin preinvasive carcinoma cervix 4 . Pregnancy ( absence confirm serum/urine βHCG ) breastfeed 5 . Known drug abuse/ alcohol abuse 6 . Legal incapacity limit legal capacity 7 . Preexisting peripheral neuropathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>adjuvant chemotherapy</keyword>
	<keyword>intraportal chemotherapy</keyword>
	<keyword>prevention</keyword>
</DOC>